摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(η5-pentamethylcyclopentadienide)chlorobis(1,3,5-triaza-7-phosphaadamantane)rhodium(III) chloride | 908356-26-3

中文名称
——
中文别名
——
英文名称
(η5-pentamethylcyclopentadienide)chlorobis(1,3,5-triaza-7-phosphaadamantane)rhodium(III) chloride
英文别名
[(pentamethylcyclopentadienyl)RhCl(1,3,5-triaza-7-phosphaadamantane)2]Cl;(η5-C5Me5)RhCl(1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane)2Cl;[Cp*RhCl(7-phospha-1,3,5-triazaadamantane)2]Cl;RhCl(η5-C5Me5)(pta)2Cl
(η5-pentamethylcyclopentadienide)chlorobis(1,3,5-triaza-7-phosphaadamantane)rhodium(III) chloride化学式
CAS
908356-26-3
化学式
C22H39ClN6P2Rh*Cl
mdl
——
分子量
623.351
InChiKey
FYDTYIQFNIFVHC-UHFFFAOYSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    描述:
    (η5-pentamethylcyclopentadienide)chlorobis(1,3,5-triaza-7-phosphaadamantane)rhodium(III) chloride1,3,5-三氮杂-7-磷杂金刚烷 为溶剂, 以69%的产率得到(η5-pentamethylcyclopentadienide)tris(1,3,5-triaza-7-phosphaadamantane)rhodium(III) dichloride
    参考文献:
    名称:
    New highly water-soluble rhodium complexes bearing 1,3,5-triaza-7-phosphaadamantane (PTA) and/or tris(hydroxymethyl) phosphine (THP)
    摘要:
    A family of cationic and neutral highly water-soluble rhodium complexes [Cp*Rh(PTA)(3)]Cl-2 (1), [Cp*RhCl2(THP)] (2), [Cp*RhCl(THP)(2)]Cl (3), and [Cp*RhCl(PTA)(THP)] Cl (4) have been synthesised and fully characterised [PTA = 1,3,5-triaza-7-phosphaadamantane; THP = tris(hydroxymethyl) phosphine]. Their water-solubility increases as the number of the phosphines coordinated to the metal centre is increased. The X-ray crystal structure of compound 2 was obtained and shows the presence of intermolecular hydrogen bonding. NMR speciation studies of [Cp*RhCl2(PTA)] in deuterated water show the existence of several equilibria involving substitution processes in which the water molecules can substitute both chloride and PTA ligands. (C) 2009 Elsevier B. V. All rights reserved.
    DOI:
    10.1016/j.ica.2009.05.041
  • 作为产物:
    描述:
    [(pentamethylcyclopentadienyl)RhCl(1,3,5-triaza-7-phosphaadamantane)(1-boranyl-1,3,5-triaza-7-phosphaadamantane]Cl 以 为溶剂, 生成 (η5-pentamethylcyclopentadienide)chlorobis(1,3,5-triaza-7-phosphaadamantane)rhodium(III) chloride
    参考文献:
    名称:
    Synthesis and reactivity of rhodium(III) pentamethylcyclopentadienyl complexes of N–B–PTA(BH3): X-ray crystal structures of [Cp∗RhCl2{N–B}–PTA(BH3)] and [Cp∗Rh{N–B–PTA(BH3)}(η2-CH2=CHPh)]
    摘要:
    The reaction between 1-boranyl-1,3,5-triaza-7-phosphaadamantane ligand N-B-PTA(BH(3)) and [Cp*RhCl(mu-Cl)](2) affords [Cp*Rh{N-B-PTA(BH(3))}Cl(2)] (3) or [Cp*Rh{N-B-PTA(BH(3))}(2)Cl]Cl (5) containing one or two P-bonded boronated PTA ligands. The hydride [Cp*Rh{N-B-PTA(BH(3))}H(2)] (8) was also obtained by reaction of 3 with NaBH(4) and alternatively by direct hydroboration of [Cp*Rh(PTA)Cl(2)] with excess NaBH(4). Moderately slow hydrolysis of the N-boranyl rhodium complexes affords dihydrogen, H(3)BO(3) and the corresponding PTA derivatives, including the water-soluble dihydride [Cp*Rh(PTA)H(2)] (9). Finally, the reaction of 8 with electron poor alkynes gives the alkene complexes [Cp*Rh{N-B-PTA(BH(3))}(eta(2)-CH(2) = CHR)] (R = Ph, 10; C(O)OEt, 11) as a mixture of rotamers eta(2)-coordinated to rhodium without affecting the N-BH(3) moiety. The X-ray crystal structures of 3 and 10 were also obtained and are here discussed. (C) 2008 Elsevier B. V. All rights reserved.
    DOI:
    10.1016/j.jorganchem.2008.04.006
点击查看最新优质反应信息

文献信息

  • Counterion-dependent deuteration of pentamethylcyclopentadiene in water-soluble cationic Rh(iii) complexes assisted by PTA
    作者:Gianluca Ciancaleoni、Sandra Bolaño、Jorge Bravo、Maurizio Peruzzini、Luca Gonsalvi、Alceo Macchioni
    DOI:10.1039/c003056m
    日期:——
    [Cp*RhCl(PTA)2]X (PTA = 7-phospha-1,3,5-triazaadamantane) undergoes an H/D exchange process between the methyl groups of Cp* and D2O whose rate depends on the coordinating ability of the counterion X−. Kinetic studies and DFT calculations indicate that deuteration involves the abstraction of a Me-Cp* proton by a coordinated OH−; the formation of the latter seems to be facilitated by the presence of the N-basic centers of PTA.
    [Cp*RhCl(PTA)2]X(PTA = 7--1,3,5-三氮杂金刚烷)在 Cp* 的甲基和 D2O 之间经历了一个 H/D 交换过程,其速率取决于反离子 X- 的配位能力。动力学研究和 DFT 计算表明,化涉及配位 OH- 对 Me-Cp* 质子的抽取;PTA 的 N 碱中心的存在似乎促进了后者的形成。
  • In Vitro Evaluation of Rhodium and Osmium RAPTA Analogues:  The Case for Organometallic Anticancer Drugs Not Based on Ruthenium
    作者:Antoine Dorcier、Wee Han Ang、Sandra Bolaño、Luca Gonsalvi、Lucienne Juillerat-Jeannerat、Gàbor Laurenczy、Maurizio Peruzzini、Andrew D. Phillips、Fabrizio Zanobini、Paul J. Dyson
    DOI:10.1021/om060394o
    日期:2006.8.1
    Reaction of the dimer [(eta(5)-C5Me5)RhCl(mu(2)-Cl)](2) with 2 or 4 equiv of the water-soluble phosphine 1,3,5-triaza-7-phosphatricyclo[3.3.1.1] decane (pta) affords [Rh(eta(5)-C5Me5)(pta)Cl-2] and [Rh(eta(5)-C5Me5)(pta)(2)Cl] Cl, respectively. Both complexes have been characterized in solution by NMR spectroscopy and in the solid state by single-crystal X-ray diffraction, the latter as the chloride and BPh4- salts. In addition, the rhodium(I) complexes [Rh(eta(5)-C5Me5)(CO)(pta)] and [Rh(eta(5)-C5H5)(pta)(2)] have been prepared lfrom [Rh(eta(5)-C5Me5)(CO)(2)] and [Rh(eta(5)-C5H5)(PPh3)(2)], respectively, by reaction with pta. An in vitro evaluation of these compounds, together with [Os(eta(6)-C10H14)(pta)Cl-2] and the well-characterized antimetastasis drug [Ru(eta(6)-C10H14)(pta)Cl-2], RAPTA-C, was undertaken using HT29 colon carcinoma, A549 lung carcinoma, and T47D breast carcinoma cells. In the HT29 cell line, the two nearest congeners to [Ru(eta(6)-C10H14)(pta)Cl-2], viz., [Rh(eta(5)-C5Me5)(pta)Cl-2] and [Os(eta(6)-C10H14)(pta)Cl-2], demonstrated very similar cytotoxicity profiles. [Rh(eta(5)-C5Me5)(pta)Cl-2] proved significantly more cytotoxic in A549 cells and [Rh(eta(5)-C5Me5)(pta)(2)Cl] Cl 3-fold more cytotoxic in T47D cells, both relative to RAPTA-C. These data suggest that the development of organometallic anticancer drugs based on the neighboring elements to ruthenium should not be overlooked.
查看更多